Revisiting CLEC12A as leukaemic stem cell marker in AML: highlighting the necessity of precision diagnostics in patients eligible for targeted therapy
| Image |  |
|---|---|
| Description | |
| Author/s |
author: Marie Toft-Petersen Peter Hokland |
| Publication date | December 5, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |